"cell lung" trang 14 - tải miễn phí từ tailieunhanh
Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)

Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC)
10    65    1
Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/ PPARγ/PTEN/mTOR signaling pathway

Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/ PPARγ/PTEN/mTOR signaling pathway
10    68    1
Modulation the crosstalk between tumorassociated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2

Modulation the crosstalk between tumorassociated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2
12    62    1
A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer

A phase I/II study of weekly nab-paclitaxel plus cisplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer
8    62    1
Application of Ventana immunocytochemical analysis on ThinPrep cytology slides for detection of ALK rearrangement in patients with advanced non–small-cell lung cancer

Application of Ventana immunocytochemical analysis on ThinPrep cytology slides for detection of ALK rearrangement in patients with advanced non–small-cell lung cancer
8    34    1
A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer

A pilot study of stereotactic body radiation therapy (SBRT) after surgery for stage III non-small cell lung cancer
8    67    1
RNA-based analysis of ALK fusions in nonsmall cell lung cancer cases showing IHC/ FISH discordance

RNA-based analysis of ALK fusions in nonsmall cell lung cancer cases showing IHC/ FISH discordance
9    42    1
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression

Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression
9    54    1
Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study

Multicenter phase II study on cisplatin, pemetrexed, and bevacizumab followed by maintenance with pemetrexed and bevacizumab for patients with advanced or recurrent nonsquamous non-small cell lung cancer: MAP study
7    61    1
PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: A diagnostic test study (LACOG 0114)

PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: A diagnostic test study (LACOG 0114)
8    71    1
Prophylactic cranial irradiation in small cell lung cancer: A systematic review and metaanalysis

Prophylactic cranial irradiation in small cell lung cancer: A systematic review and metaanalysis
10    35    1
Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome

Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome
9    74    1
Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: A systematic review

Impact on prognosis of rebiopsy in advanced non-small cell lung cancer patients after epidermal growth factor receptor-tyrosine kinase inhibitor treatment: A systematic review
5    61    1
Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia

Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia
7    58    1
MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway

MicroRNA-148b regulates tumor growth of non-small cell lung cancer through targeting MAPK/JNK pathway
11    32    1
Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage

Cost burden associated with advanced non-small cell lung cancer in Europe and influence of disease stage
11    81    1
Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinumbased chemotherapy

Pretreatment albumin/fibrinogen ratio as a promising predictor for the survival of advanced non small-cell lung cancer patients undergoing first-line platinumbased chemotherapy
8    32    1
EGFR mutation frequency in Middle East and African non-small cell lung cancer patients: A systematic review and metaanalysis

EGFR mutation frequency in Middle East and African non-small cell lung cancer patients: A systematic review and metaanalysis
6    42    1
Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)

Efficacy of anti-PD-1/PD-L1 antibodies after discontinuation due to adverse events in non-small cell lung cancer patients (HANSHIN 0316)
6    36    1
A molecular and staging model predicts survival in patients with resected non-small cell lung cancer

A molecular and staging model predicts survival in patients with resected non-small cell lung cancer
8    39    1